Search
for

    Sort by

    Research 391–420 of 1000+

    1. Finasteride and androgenic alopecia; from therapeutic options to medical implications Journal of Dermatological Treatment · 2019 · 13 citations
    2. Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia Journal of pharmaceutical sciences · 2013 · 13 citations
    3. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    4. Clinics in diagnostic imaging (221) Singapore Medical Journal · 2024
    5. “Acute Pancreatitis Following Finasteride Toxicity: A Rare Case Report" Research Square (Research Square) · 2024
    6. Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana Planta Medica · 2002 · 22 citations
    7. Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns Biomedicine & Pharmacotherapy · 2017 · 54 citations
    8. 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency European Urology · 1991 · 8 citations
    9. The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study Australasian Journal of Dermatology · 2024
    10. Dutasteride/finasteride Reactions Weekly · 2021
    11. Tissue Expansion in the Head and Neck Atlas of the Oral and Maxillofacial Surgery Clinics · 2019 · 5 citations
    12. Management of autoimmune associated alopecia areata Nursing Standard · 2010 · 3 citations
    13. Management of autoimmune associated alopecia areata Nursing Standard · 2010 · 1 citations
    14. Structure of human type II 5 alpha-reductase gene. Endocrinology · 1992 · 124 citations
    15. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    16. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men Advances in Experimental Medicine and Biology · 2017 · 31 citations
    17. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    18. Post-finasteride syndrome – does it really exist? The Aging Male · 2019 · 7 citations
    19. Association between male pattern baldness and prostate disease: A meta-analysis Urologic Oncology: Seminars and Original Investigations · 2017 · 7 citations
    20. 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis International Braz J Urol · 2018 · 4 citations
    21. The Effects of Oral 5-alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in Rat Model. PubMed · 2019 · 2 citations
    22. Should Finasteride Be Routinely Given Preoperatively for TURP? ISRN Urology (Print) · 2013 · 2 citations
    23. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    24. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    25. A Natural Product Molecule of Artocarpus Heterophyllus Reverses Inflammation Due to the Effect of Acute Exposure of Prostate Tissue to Testosterone Enanthate in Wistar Rats Journal of Cancer Therapy and Research · 2024
    26. Androgenetic Alopecia: A Review Nigerian Postgraduate Medical Journal · 2024
    27. EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA Journal of Men s Health · 2020
    28. Medical, dental and dual-degree ‘Oral-Maxillofacial’ signatures — what have I seen over the past 22 years? British Journal of Oral & Maxillofacial Surgery · 2021 · 1 citations
    29. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    30. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations